- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 193 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 178 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 216 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 278 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 205 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 178 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 178 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 221 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 172 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 275 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 480 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 74 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 78 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 580 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 565 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 73 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 242 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 66 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 217 Pages
Global
From €5324EUR$5,850USD£4,522GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more